Aged at least 18 years 
The presence of a solid, malignant tumour, excluding lymphoma, that is resistance to standard therapies or for which no standard therapies exist 
The presence of at least one lesion that can be accurately assessed at baseline by Computerised Tomography (CT), Magnetic Resonance Imaging (MRI) or plain X-ray and is suitable for repeated assessment 
Estimated life expectancy of more than 12 weeks 

NCT01895946_inc_T1
Value
at least 18 years
NCT01895946_inc_T2
Person
Aged
NCT01895946_inc_T3
Condition
solid, malignant tumour
NCT01895946_inc_T4
Condition
lymphoma
NCT01895946_inc_T5
Negation
excluding
NCT01895946_inc_T6
Qualifier
resistance to standard therapies
NCT01895946_inc_T7
Qualifier
for which no standard therapies exist
NCT01895946_inc_T8
Scope
resistance to standard therapies or for which no standard therapies exist
NCT01895946_inc_T9
Multiplier
at least one
NCT01895946_inc_T10
Condition
lesion
NCT01895946_inc_T11
Qualifier
accurately assessed at baseline
NCT01895946_inc_T12
Procedure
Computerised Tomography (CT)
NCT01895946_inc_T13
Procedure
Magnetic Resonance Imaging (MRI)
NCT01895946_inc_T14
Procedure
plain X-ray
NCT01895946_inc_T15
Qualifier
suitable for repeated assessment
NCT01895946_inc_T16
Scope
Computerised Tomography (CT), Magnetic Resonance Imaging (MRI) or plain X-ray
NCT01895946_inc_T17
Value
more than 12 weeks
NCT01895946_inc_T18
Observation
Estimated life expectancy